Article Information
History
- June 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sebastian Bruno Ulrich Jordi1,2,
- Brian Matthew Lang3,
- Bianca Auschra4,
- Roland von Känel4,
- Luc Biedermann2,
- Thomas Greuter2,
- Philipp Schreiner2,
- Gerhard Rogler2,
- Niklas Krupka1,
- Michael Christian Sulz5,
- Benjamin Misselwitz1,2,*,
- Stefan Begré6,7,*,† and
- on behalf of the Swiss IBD cohort study group#
- 1Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland
- 2Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland
- 3Clinic for Transplantation Immunology and Nephrology (Swiss Transplant Cohort Study), University Hospital of Basel, Basel, Switzerland
- 4Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich and University of Zurich, Zurich, Switzerland
- 5Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen, St. Gallen, Switzerland
- 6Neurology, Department of Biomedical Research, Bern University Hospital, University of Bern, Bern, Switzerland
- 7ISFOM - Institute of Stress Diseases and Stressmanagement, Zurich, Switzerland
- ↵†Correspondence
Stefan Begré, MD, Address: ISFOM - Institute of Stress Diseases and Stressmanagement, Weinbergstrasse 139, CH-8006 Zurich, Switzerland, E-mail address: stefan.begre{at}dbmr.unibe.ch
↵* Both authors contributed equally and share last authorship
Authors’ contributions The study was conceived and designed by S.B.U.J., B.M. and S.B. Statistical analyses were performed by S.B.U.J. and B.M.L. The manuscript was written by S.B.U.J., B.M. and S.B. The following authors have contributed to data interpretation and revised the manuscript for important intellectual content: B.M.L., R.v.K., B.A., L.B., T.G., P.S., G.R., N.K. and M.C.S. All authors approved the final version of the manuscript.
Posted June 30, 2020.
Depressive symptoms and single nucleotide polymorphisms predict clinical recurrence of inflammatory bowel disease
